News
Biogen to invest further $2bn in North Carolina’s Research Triangle Park
Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina. The latest manufacturing investment will support the ongoing development of Biogen's late-stage clinical pipeline.
Biogen to boost US manufacturing footprint with $2bn North Carolina investment
Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The upcoming investment in the state’s Research Triangle Park (RTP), where Biogen first broke ground in 1995, is aimed at fuelling the “continued advancement” of the company’s late-stage clinical pipeline.
Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...
One of North Carolina’s largest life sciences companies, Biogen Inc. (Nasdaq BIIB), is celebrating its 30th anniversary in the state by announcing that it intends to invest an additional $2 billion at ...
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback